Controlled Drugs and Substances Act

From Wikipedia, the free encyclopedia - View original article

 
Jump to: navigation, search

The Controlled Drugs and Substances Act is Canada's federal drug control statute. Passed in 1996 by the Chrétien government, it repeals the Narcotic Control Act and Parts III and IV of the Food and Drug Act and establishes eight Schedules of controlled substances and two Classes of precursors. It provides that "The Governor in Council may, by order, amend any of Schedules I to VIII by adding to them or deleting from them any item or portion of an item, where the Governor in Council deems the amendment to be necessary in the public interest."

The Act serves as the implementing legislation for the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.

(Incomplete) List of Drugs[edit]

A complete list of drugs scheduled in Canada's Controlled Drugs and Substances Act can be found here. This list is what is reflected below. Some less common chemicals are omitted.

On March 12, 2012, controversial Bill C-10, the Safe Streets and Communities Act was passed into law. Amphetamines and their isomers, derivatives, and analogues, including MDA and MDMA (Ecstasy), as well as potential "date rape drugs" Rohypnol and GHB were rescheduled from Schedule III to Schedule I. Dealers of Schedule I drugs now face mandatory minimum sentencing of 1 year imprisonment. Also, the rescheduling imposes harsher punishment for possession

Schedule I[edit]

        (1)         Opium        (2)         Codeine (methylmorphine)        (3)         Morphine (7,8–didehydro–4,5–epoxy–17–methylmorphinan–3,6–diol)        (4)         Thebaine (paramorphine) 
    and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:        (5)         Acetorphine (acetyletorphine)        (6)         Acetyldihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol acetate)        (7)         Benzylmorphine (7,8–didehydro–4,5–epoxy–17–methyl–3–(phenylmethoxy) morphinan–6–ol)        (8)         Codoxime (dihydrocodeinone O–(carboxymethyl) oxime)        (9)         Desomorphine (dihydrodeoxymorphine)        (10)         Diacetylmorphine (heroin)        (11)         Dihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol)        (12)         Dihydromorphine (4,5–epoxy–17–methylmorphinan–3,6–diol)        (13)         Ethylmorphine (7,8–didehydro–4,5–epoxy–3–ethoxy–17–methylmorphinan–6–ol)        (14)         Etorphine (tetrahydro–7α–(1–hydroxy–1–methyl-butyl)–6,14–endo–ethenooripavine)        (15)         Hydrocodone (dihydrocodeinone)        (16)         Hydromorphinol (dihydro–14–hydroxymorphine)        (17)         Hydromorphone (dihydromorphinone)        (18)         Methyldesorphine (Δ6–deoxy–6–methylmorphine)        (19)         Methyldihydromorphine (dihydro–6–methylmorphine)        (20)         Metopon (dihydromethylmorphinone)        (21)         Morphine–N–oxide (morphine oxide)        (22)         Myrophine (benzylmorphine myristate)        (23)         Nalorphine (N–allylnormorphine)        (24)         Nicocodine (6–nicotinylcodeine)        (25)         Nicomorphine (dinicotinylmorphine)        (26)         Norcodeine (N–desmethylcodeine)        (27)         Normorphine (N–desmethylmorphine)        (28)         Oxycodone (dihydrohydroxycodeinone)        (29)         Oxymorphone (dihydrohydroxymorphinone)        (30)         Pholcodine (3–[2–(4–morpholinyl)ethyl]morphine)        (31)         Thebacon (acetyldihydrocodeinone) 
    but not including        (32)         Apomorphine (5,6,6a,7–tetrahydro–6–methyl–4H–dibenzo[de,g]quinoline–10,11–diol)        (33)         Cyprenorphine (N–(cyclopropylmethyl)–6,7,8,14–tetrahydro–7α–(1–hydroxy–1–methylethyl)–6,14–endo–ethenonororipavine)        (34)         Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol)        (34.1)         Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one)        (34.2)         Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one)        (35)         Narcotine (6,7–dimethoxy–3–(5,6,7,8–tetra-hydro–4–methoxy–6–methyl–1,3–dioxolos [4,5–g]isoquinolin–5–yl)–1(3H)–isobenzofuranone)        (36)         Papaverine (1–[(3,4–dimethoxyphenyl)methyl]–6,7–dimethoxyisoquinoline)        (37)         Poppy seed  
        (1)         Coca leaves        (2)         Cocaine (benzoylmethylecgonine)        (3)         Ecgonine (3–hydroxy–2–tropane carboxylic acid)  
        (1)         Allylprodine (3–allyl–1–methyl–4–phenyl–4–piperidinol propionate)        (2)         Alphameprodine (α–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)        (3)         Alphaprodine (α–1,3–dimethyl–4–phenyl–4–piperidinol propionate)        (4)         Anileridine (ethyl 1–[2–(p–aminophenyl)ethyl]–4–phenylpiperidine–4–carboxylate)        (5)         Betameprodine (ß–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)        (6)         Betaprodine (ß–1,3–dimethyl–4–phenyl–4–piperidinol propionate)        (7)         Benzethidine (ethyl 1–(2–benzyloxyethyl)–4–phenylpiperidine–4–carboxylate)        (8)         Diphenoxylate (ethyl 1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)        (9)         Difenoxin (1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)        (10)         Etoxeridine (ethyl 1–[2–(2–hydroxyethoxy) ethyl]–4–phenylpiperidine–4–carboxylate)        (11)         Furethidine (ethyl 1–(2–tetrahydrofurfury loxyethyl)–4–phenylpiperidine–4–carboxylate)        (12)         Hydroxypethidine (ethyl 4–(m–hydroxyphenyl)–1–methylpiperidine–4–carboxylate)        (13)         Ketobemidone (1–[4–(m–hydroxyphenyl)–1–methyl–4–piperidyl]–1–propanone)        (14)         Methylphenylisonipecotonitrile (4–cyano–1–methyl–4–phenylpiperidine)        (15)         Morpheridine (ethyl 1–(2–morpholinoethyl)–4–phenylpiperidine–4–carboxylate)        (16)         Norpethidine (ethyl 4–phenylpiperidine–4–carboxylate)        (17)         Pethidine (ethyl 1–methyl–4–phenylpiperidine–4–carboxylate)        (18)         Phenoperidine (ethyl 1–(3–hydroxy–3–phenylpropyl)–4–phenylpiperidine–4–carboxylate)        (19)         Piminodine (ethyl 1–[3–(phenylamino)propyl]–4–phenylpiperidine–4–carboxylate)        (20)         Properidine (isopropyl 1–methyl–4–phenylpiperidine–4–carboxylate)        (21)         Trimeperidine (1,2,5–trimethyl–4–phenyl–4–piperidinol propionate)        (22)         Pethidine Intermediate C (1–methyl–4–phenylpiperidine–4–carboxylate) 
    but not including        (23)         Carbamethidine (ethyl 1–(2–carbamylethyl)–4–phenylpiperidine–4–carboxylate)        (24)         Oxpheneridine (ethyl 1–(2–hydroxy–2–phenylethyl)–4–phenylpiperidine–4–carboxylate)  
        (1)         Proheptazine (hexahydro–1,3–dimethyl–4–phenyl–1H–azepin–4–ol propionate) 
    but not including        (2)         Ethoheptazine (ethyl hexahydro–1–methyl–4–phenyl–azepine–4–carboxylate)        (3)         Metethoheptazine (ethyl hexahydro–1,3–dimethyl–4–phenylazepine–4–carboxylate)        (4)         Metheptazine (ethyl hexahydro–1,2–dimethyl–4–phenylazepine–4–carboxylate)  
        (1)         Dimethylaminodiphenylbutanonitrile (4–cyano–2–dimethylamino–4,4–diphenylbutane)        (2)         Dipipanone (4,4–diphenyl–6–piperidino–3–heptanone)        (3)         Isomethadone (6–dimethylamino–5–methyl–4,4–diphenyl–3–hexanone)        (4)         Methadone (6–dimethylamino–4,4–diphenyl–3–heptanone)        (5)         Normethadone (6–dimethylamino–4,4–diphenyl–3–hexanone)        (6)         Norpipanone (4,4–diphenyl–6–piperidino–3–hexanone)        (7)         Phenadoxone (6–morpholino–4,4–diphenyl–3–heptanone)  
        (1)         Acetylmethadol (6–dimethylamino–4,4–diphenyl–3–heptanol acetate)        (2)         Alphacetylmethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)        (3)         Alphamethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol)        (4)         Betacetylmethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)        (5)         Betamethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol)        (6)         Dimepheptanol (6–dimethylamino–4,4–diphenyl–3–heptanol)        (7)         Noracymethadol (α–6–methylamino–4,4–diphenyl–3–heptanol acetate)  
        (1)         Dimenoxadol (dimethylaminoethyl 1–ethoxy–1,1–diphenylacetate)        (2)         Dioxaphetyl butyrate (ethyl 2,2–diphenyl–4–morpholinobutyrate)        (3)         Dextropropoxyphene ([S–(R*,S*)]–α–[2–(dimethylamino)–1–methylethyl]–α–phenylbenzeneethanol, propanoate ester)  
        (1)         Diethylthiambutene (N,N–diethyl–1–methyl–3,3–di–2–thienylallylamine)        (2)         Dimethylthiambutene (N,N,1–trimethyl–3,3–di–2–thienylallylamine)        (3)         Ethylmethylthiambutene (N–ethyl–N,1–dimethyl–3,3–di–2–thienylallylamine)  
        (1)         Dextromoramide (d–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)        (2)         Diphenylmorpholinoisovaleric acid (2–methyl–3–morpholino–1,1–diphenylpropionic acid)        (3)         Levomoramide (l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)        (4)         Racemoramide (d,l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl) pyrrolidine)  
        (1)         Buprenorphine (17–(cyclopropylmethyl)–α–(1,1–dimethylethyl)–4,5–epoxy–18,19–dihydro–3–hydroxy–6–methoxy–α–methyl–6,14–ethenomorphinan–7–methanol)        (2)         Drotebanol (6ß,14–dihydroxy–3,4–dimethoxy–17–methylmorphinan)        (3)         Levomethorphan (l–3–methoxy–17–methylmorphinan)        (4)         Levorphanol (l–3–hydroxy–17–methylmorphinan)        (5)         Levophenacylmorphan (l–3–hydroxy–17–phenacylmorphinan)        (6)         Norlevorphanol (l–3–hydroxymorphinan)        (7)         Phenomorphan (3–hydroxy–17–(2–phenylethyl)morphinan)        (8)         Racemethorphan (d,1–3–methoxy–17–methylmorphinan)        (9)         Racemorphan (d,l–3–hydroxy–N–methylmorphinan) 
    but not including        (10)         Dextromethorphan (d–1,2,3,9,10,10a–hexahydro–6–methoxy–11–methyl–4H–10,4a–iminoethano–phenanthren)        (11)         Dextrorphan (d–1,2,3,9,10,10a–hexahydro–11–methyl–4H–10,4a–iminoethanophenanthren–6–ol)        (12)         Levallorphan (l–11–allyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol)        (13)         Levargorphan (l–11–propargyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol)        (14)         Butorphanol (17–(cyclobutylmethyl)morphinan–3,14–diol)        (15)         Nalbuphine (17–(cyclobutylmethyl)–4,5α–epoxymorphinan–3,6α, 14–triol)  
        (1)         Phenazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–phenethyl–2,6–methano–3–benzazocin–8–ol)        (2)         Metazocine (1,2,3,4,5,6–hexahydro–3,6,11–trimethyl–2,6–methano–3–benzazocin–8–ol)        (3)         Pentazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(3–methyl–2–butenyl)–2,6–methano–3–benzazocin–8–ol) 
    but not including        (4)         Cyclazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(cyclopropylmethyl)–2,6–methano–3–benzazocin–8–ol)  
        (1)         Diampromide (N–[2–(methylphenethylamino)propyl] propionanilide)        (2)         Phenampromide (N–(1–methyl–2–piperidino) ethyl) propionanilide)        (3)         Propiram (N–(1–methyl–2–piperidinoethyl)–N–2–pyridylpropionamide)  
        (1)         Clonitazene (2–(p–chlorobenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)        (2)         Etonitazene (2–(p–ethoxybenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)        (3)         Bezitramide (1–(3–cyano–3,3–diphenylpropyl)–4–(2–oxo–3–propionyl–1–benzimidazolinyl)–piperidine) 
        (1)         Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone) 
        (1)         Acetyl–α–methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] acetanilide)        (2)         Alfentanil (N–[1–[2–(4–ethyl–4,5–dihydro–5–oxo–1H–tetrazol–1–yl)ethyl]–4–(methoxymethyl)–4–piperidyl]propionanilide)        (3)         Carfentanil (methyl 4–[(1–oxopropyl)phenylamino]–1–(2–phenethyl)–4–piperidinecarboxylate)        (4)         p–Fluorofentanyl (4′fluoro–N–(1–phenethyl–4–piperidyl) propionanilide)        (5)         Fentanyl (N–(1–phenethyl–4–piperidyl) propionanilide)        (6)         ß–Hydroxyfentanyl (N–[1–(ß–hydroxyphenethyl)–4–piperidyl] propionanilide)        (7)         ß–Hydroxy–3–methylfentanyl (N–[1–(ß–hydroxyphenethyl)–3–methyl–4–piperidyl] propionanilide)        (8)         α–Methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] propionanilide)        (9)         α–Methylthiofentanyl (N–[1–[1–methyl–2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)        (10)         3–Methylfentanyl (N–(3–methyl–1–phenethyl–4–piperidyl) propionanilide)        (11)         3–Methylthiofentanyl (N–[3–methyl–1–[2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)        (11.1)         Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)        (12)         Sufentanil (N–[4–(methoxymethyl)–1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)        (13)         Thiofentanyl (N–[1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)  
    17.1     Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues 
        (1)         amphetamine (α-methylbenzene-ethanamine)        (2)         N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)        (3)         4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)        (4)         3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)        (5)         2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)        (6)         4-methoxyamphetamine (4-methoxy-α-methylbenzene­ethanamine)        (7)         2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzene­ethanamine)        (8)         N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)        (9)         4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)        (10)         5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzo­dioxole-5-ethanamine)        (11)         N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)        (12)         N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzo­dioxole-5-ethanamine)        (13)         4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)        (14)         4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)        (15)         4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)        (16)         4-ethoxyamphetamine (4-ethoxy-α-methylbenzene­ethanamine)        (17)         Benzphetamine (N-benzyl-N,α-dimethylbenzene­ethanamine)        (18)         N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzo­dioxole-5-ethanamine)        (19)         N-(2-Hydroxyethyl)-α-meth-ylbenzene­ethanamine        (20)         N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxyla­mine)        (21)         3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzene­ethanamine)  

Schedule II[edit]

Schedule III[edit]

Schedule IV[edit]

Schedule V[edit]

Schedule VI (Precursors)[edit]

Laws[edit]

Possession[edit]

If treated as an indictable offence, the penalty is:

Schedule I: Maximum 7 years imprisonment
Schedule II: (exceeding amounts set in Schedule VIII): Maximum 5 years imprisonment
Schedule III: (Requires a prescription or license to legally possess.) Maximum 3 years imprisonment
Schedule IV: It is not an offence to possess a Schedule IV substance for personal use; however, Subsection (2) of Section (4) of the CDSA states that "no person shall seek or obtain a substance or authorization from a practitioner to obtain a substance in schedules I through IV." Subsection (7) then states that it is an indictable offence to contravene subsection (2). Therefore, it is an indictable offence to attempt to acquire a Schedule IV substance but not an offence for possession. Section 5 provides that possession for the purpose of trafficking of a Schedule IV substance is an offence.

If treated as a summary conviction offence, the penalty is:

Maximum $1000 fine for first offence and/or maximum 6 months imprisonment.
Maximum $2000 fine for subsequent offence and/or maximum 1 year imprisonment.

Note: For amounts not exceeding those set in Schedule VIII, maximum fine of $1000 and/or maximum 6 months imprisonment is the only punishment.

Trafficking/Possession for the Purpose of[edit]

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II (exceeding amounts set in Schedule VII): Maximum life imprisonment

Schedule II (not exceeding amounts set in Schedule VII): Maximum 5 years imprisonment
Schedule III: Maximum 10 years imprisonment
Schedule IV: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III: Maximum 18 months imprisonment
Schedule IV: Maximum 1 year imprisonment

Exportation/Possession for the Purpose of[edit]

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II: Maximum life imprisonment
Schedule III or Schedule IV: Maximum 10 years imprisonment
Schedule V or Schedule VI: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III or Schedule IV: Maximum 18 months imprisonment
Schedule V or Schedule VI: Maximum 1 year imprisonment

Production[edit]

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II (excluding cannabis): Maximum life imprisonment
Cannabis: Maximum 7 years imprisonment
Schedule III: Maximum 10 years imprisonment
Schedule IV: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III: Maximum 18 months imprisonment
Schedule IV: Maximum 1 year imprisonment

Amendments to the act[edit]

In November 2007, the Justice Minister Rob Nicholson introduced Bill C-26, which proposed a number of mandatory minimum penalties imposed on those who commit drug offenses. On February 27, 2009 bill C-15, a re-introduction of C-26 received first reading in the 2nd Session of the 40th Parliament of Canada.[3] On June 9, 2009, the House of Commons passed Bill C-15, and it is now awaiting study and approval by the Senate. On December 14, 2009, the Senate passed Bill C-15, with some amendments, for approval by the House of Commons. When the Canadian Parliament dissolved in a prorogation on January 31, 2010, Bill C15, along with all legislation on the table, fell. However it will be reintroduced when parliament resumes with a new session in March. In the official press release they explain "...We will reintroduce in their original form the consumer safety law (Bill C-6) and the anti-drug-crime law (Bill C-15).... We will seek Opposition agreement to proceed expeditiously with other Government legislation -- particularly laws urgently needed to fight crime...."

The current session of parliament passed Bill C-10 early in 2012, receiving Royal Assent in March. The final legislation sees changes made to four areas of the CDSA, outlining mandatory minimum sentences for offences relating to the trafficking and production of various controlled substances. Mandatory minimum sentencing does not apply to simple possession and trafficking in smaller amounts.

See also[edit]

References[edit]

http://www.parl.gc.ca/LegisInfo/BillDetails.aspx?Language=E&Mode=1&billId=5120829&View=0

  1. ^ "Controlled Drugs and Substances Act". Retrieved 17 December 2013. 
  2. ^ "Controlled Drugs and Substances Act". 
  3. ^ "Bill C-15: An Act to amend the Controlled Drugs and Substances Act and to make related and consequential amendments to other Acts". 

External links[edit]